Different Anti-inflammatory Drugs on High-Sensitivity C-Reactive Protein in Patients After Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial.

Yu, Miao; Zhu, Zheng-Feng; Yang, Fen; Yuan, Yuan-Fan; Liao, Shu-De; Liu, Mei-Lin; Cheng, Xiang

Yu, Miao; Zhu, Zheng-Feng; Yang, Fen; Yuan, Yuan-Fan; Liao, Shu-De; Liu, Mei-Lin; Cheng, Xiang.

Affiliation

Yu M; Department of Cardiology.
Zhu ZF; Hubei Key Laboratory of Biological Targeted Therapy; and.
Yang F; Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuan YF; Department of Cardiology.
Liao SD; Hubei Key Laboratory of Biological Targeted Therapy; and.
Liu ML; Hubei Provincial Engineering Research Center of Immunological Diagnosis and Therapy for Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Cheng X; Department of Cardiology.

J Cardiovasc Pharmacol ; 83(3): 234-242, 2024 Mar 01.

Article de En | MEDLINE | ID: mdl-37944130

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie des artères coronaires / Diterpènes de type kaurane / Ortho-Aminobenzoates / Intervention coronarienne percutanée Limites: Female / Humans / Male / Middle aged Langue: En Journal: J Cardiovasc Pharmacol Année: 2024 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google